Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection

References

• Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259–264. doi:10.1038/s41586-021-03553-9
   PubMed Web of Science ®Google Scholar
• Bull-Otterson L, Baca S, Saydah S, et al. Post-COVID conditions among adult COVID-19 survivors aged 18-64 and ≥65 years- United States, March 2020-November 2021. MMWR Morb Mortal Wkly Rep. 2022;71:713–717. doi:10.15585/mmwr.mm7121e1
   Web of Science ®Google Scholar
• Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019
   PubMedGoogle Scholar
• Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022;94(1):253–262. doi:10.1002/jmv.27309
   PubMed Web of Science ®Google Scholar
• Weinreich DM, Sivapalasingam S, Norton T, et al. REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. N Engl J Med. 2021;385(23):e81. doi:10.1056/NEJMoa2108163
   PubMed Web of Science ®Google Scholar
• CDC. Long COVID or Post-COVID Conditions; 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html. Accessed July 6, 2022.
   Google Scholar
• Stam HJ, Stucki G, Bickenbach J, et al. Covid-19 and Post Intensive Care Syndrome: a Call for Action. J Rehabil Med. 2020;52(4):jrm00044. doi:10.2340/16501977-2677
   PubMed Web of Science ®Google Scholar
• O’Dowd A. Covid-19: third of people infected have long term symptoms. BMJ. 2021;373:n1626. doi:10.1136/bmj.n1626
   PubMedGoogle Scholar
• Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. 2021;72(11):384–396. doi:10.33588/rn.7211.2021230
   PubMed Web of Science ®Google Scholar
• Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): an Integrative Classification. Int J Environ Res Public Health. 2021;18(5):2621. doi:10.3390/ijerph18052621
   PubMed Web of Science ®Google Scholar
• Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi:10.1038/s41598-021-95565-8
   PubMed Web of Science ®Google Scholar
• Vehar S, Boushra M, Ntiamoah P, Biehl M. Post-acute sequelae of SARS-CoV-2 infection: caring for the ‘long-haulers’. Cleve Clin J Med. 2021;88(5):267–272. doi:10.3949/ccjm.88a.21010
   PubMed Web of Science ®Google Scholar
• WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1]x. Accessed July 6, 2022.
   Google Scholar
• Ledford H. How common is long COVID? Why studies give different answers. Nature. 2022;606(7916):852–853. doi:10.1038/d41586-022-01702-2
   PubMed Web of Science ®Google Scholar
• Reardon S. Long COVID risk falls only slightly after vaccination, huge study shows. Nature. 2022. doi:10.1038/d41586-022-01453-0
   Google Scholar
• Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461–1467. doi:10.1038/s41591-022-01840-0
   PubMed Web of Science ®Google Scholar
• Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55. doi:10.1016/S1473-3099(21)00460-6
   PubMed Web of Science ®Google Scholar
• CDC National Center for Health Statistics (NCHS). The Household Pulse Survey. US Census Bureau Data collected Jun1-13, 2022. Available from: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm. Accessed July 6, 2022.
   Google Scholar
• Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75(3):e13746. doi:10.1111/ijcp.13746
   PubMed Web of Science ®Google Scholar
• Mannan A, Sutingco N, Djurkovic S, et al. Service Line Care Delivery Model for COVID-19 Patient-Centric Care. Am J Manag Care. 2022;28(3):e80–e87. doi:10.37765/ajmc.2022.88731
   PubMed Web of Science ®Google Scholar
• Verderese JP, Stepanova M, Lam BP. Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): a Real-World Experience. Clin Infect Dis. 2022;74(6):1063–1069. doi:10.1093/cid/ciab579
   PubMed Web of Science ®Google Scholar
• Maria Stepanova BP, Lam EY, et al. The Impact of Variants and Vaccination on the Mortality and Resource Utilization of Hospitalized Patients with COVID-19. BMC Infect Dis. 2022;22(1):702. doi:10.1186/s12879-022-07657-z
   PubMed Web of Science ®Google Scholar
• Lam BP, Stepanova M, Venkatesan C, et al. Outcomes of Hospitalized Patients with COVID-19 During the Course of the Pandemic in a Fully Integrated Health System. PLoS One. 2022;17(2):e0263417. doi:10.1371/journal.pone.0263417
   PubMed Web of Science ®Google Scholar
• World Health Organization (2018). International classification of functioning, disability and health. Available from: http://www.who.int/classifications/icf/en/3.12.22. Accessed September 16, 2022.
   Google Scholar
• de Avila L, Price JK, Stepanova M, et al. Regular Exercise is Associated with Low Fatigue Levels and Good Functional Outcomes Post-COVID-19: a Prospective Observational Study. AJPMR. 2023,Feb;1:1097. doi:10.1097/PHM.0000000000002197
   Google Scholar
• Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J. 1982;284(6329):1607–1608. doi:10.1136/bmj.284.6329.1607
   PubMed Web of Science ®Google Scholar
• Agarwala P, Salzman SH. Six-Minute Walk Test: clinical Role, Technique, Coding, and Reimbursement. Chest. 2020;157(3):603–611. doi:10.1016/j.chest.2019.10.014
   PubMed Web of Science ®Google Scholar
• Wang YC, Bohannon RW, Li X, Sindhu B, Kapellusch J. Hand-Grip Strength: normative Reference Values and Equations for Individuals 18 to 85 Years of Age Residing in the United States. J Orthop Sports Phys Ther. 2018;48(9):685–693. doi:10.2519/jospt.2018.7851
   PubMed Web of Science ®Google Scholar
• Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil. 1985;66(2):69–74.
   PubMed Web of Science ®Google Scholar
• Selman JP, de Camargo AA, Santos J, Lanza FC, Dal Corso S. Reference equation for the 2-minute walk test in adults and the elderly. Respir Care. 2014;59(4):525–530. doi:10.4187/respcare.02649
   PubMed Web of Science ®Google Scholar
• Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63–74. doi:10.1016/S0885-3924(96)00274-6
   PubMed Web of Science ®Google Scholar
• Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage. 2002;24(6):547–561. doi:10.1016/S0885-3924(02)00529-8
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Hyattsville, MD: u.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2015-2016. Available from: https://wwwn.cdc.gov/Nchs/Nhanes/2015-2016/PFQ_I.htm. Accessed September 16, 2022.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). Hyattsville, MD: u.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011-2012. Available from: https://wwwn.cdc.gov/Nchs/Nhanes/2011-2012/MCQ_G.htm. Accessed September 16, 2022.
   Google Scholar
• Fasel D, Kunze U, Elzi L, et al. A short tool to screen HIV-infected patients for mild neurocognitive disorders - a pilot study. BMC Psychol. 2014;2(1):21. doi:10.1186/2050-7283-2-21
   PubMedGoogle Scholar
• Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000;88(9):2164–2171. doi:10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi:10.1001/archinte.166.10.1092
   PubMed Web of Science ®Google Scholar
• Reinius M, Wettergren L, Wiklander M, Svedhem V, Ekström AM, Eriksson LE. Development of a 12-item short version of the HIV stigma scale. Health Qual Life Outcomes. 2017;15(1):115. doi:10.1186/s12955-017-0691-z
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN). NCCN Distress Thermometer and Problem List for Patients (DT). Version 2. 2020. Available from: www.nccn.org. Accessed September 16, 2022.
   Google Scholar
• van Hout B, Janssen MF, Feng YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–715. doi:10.1016/j.jval.2012.02.008
   PubMed Web of Science ®Google Scholar
• Wechsler DD, Coalson L, Raiford SE. ”WAIS-Iv”. Wechsler Adult Intelligence Scale: Fourth Edition. Technical and Interpretative Manual. San Antonio, TX: NCS Pearson; 2008.
   Google Scholar
• Delis DC, Kaplan E, Kramer JH. Delis-Kaplan executive function system. Assessment. 2001.
   Google Scholar
• Alger HM, Rutan C, Williams JH. American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines. Circ Cardiovasc Qual Outcomes. 2020;13(8):e006967. doi:10.1161/CIRCOUTCOMES.120.006967
   PubMed Web of Science ®Google Scholar
• UK Office of National Statistics (ONS). Self-reported long COVID after infection with the Omicron variant in the UK: 6 May 2022. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/6may2022. Accessed July 6, 2022.
   Google Scholar
• Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263–2264. doi:10.1016/S0140-6736(22)00941-2
   PubMed Web of Science ®Google Scholar
• Lancet T. The Lancet, The COVID-19 pandemic in 2023: far from over. Lancet. 2023;401(10371):79. doi:10.1016/S0140-6736(23)00050-8
   PubMed Web of Science ®Google Scholar
• Chavda VP, Patel AB, Vaghasiya DD. SARS-CoV-2 variants and vulnerability at the global level. J Med Virol. 2022;94(7):2986–3005. doi:10.1002/jmv.27717
   PubMed Web of Science ®Google Scholar
• Chavda VP, Patel AB, Pandya A, et al. Future Science OA. Assessment. 2023;8(9):543.
   Google Scholar